Analysts expect Vistagen Therapeutics, Inc. to report revenue of 473,797.50 for Q2 26, against a range of 444,552.82 to 503,042.18. The most recent reported quarter, Q1 26, came in at 1.48 M, a 185.9% beat against the 517,585.00 consensus.
| Metric | Q1 24 | Q2 24 | Q3 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 84,000.00 | 183,000.00 | 234,000.00 | 244,000.00 | 258,000.00 | 303,000.00 | 464,000.00 | 1.48 M | - | - | - | - | - | - | - | - | |||||||||||
| High Estimate | 308,807.48 | 253,993.09 | 337,603.83 | 710,590.92 | 389,425.94 | 389,082.15 | 422,197.01 | 562,803.81 | 503,042.18 | 572,855.95 | 566,219.56 | 739,902.23 | -80,367.63 | -279,467.78 | -323,566.50 | 5.49 M | |||||||||||
| Low Estimate | 260,577.70 | 225,102.21 | 303,668.95 | 615,008.56 | 318,963.82 | 318,885.07 | 353,988.89 | 472,366.19 | 444,552.82 | 496,904.05 | 488,170.44 | 689,128.75 | -91,047.65 | -317,470.68 | -380,203.82 | 4.90 M | |||||||||||
| Consensus Estimate | 284,692.59 | 239,547.65 | 320,636.39 | 662,799.74 | 354,194.88 | 353,983.61 | 388,092.95 | 517,585.00 | 473,797.50 | 534,880.00 | 527,195.00 | 714,515.49 | -85,707.64 | -298,469.23 | -351,885.16 | 5.19 M |
Analysts expect Vistagen Therapeutics, Inc. to report earnings per share of -0.40 for Q2 26, against a range of -0.42 to -0.38. The most recent reported quarter, Q1 26, came in at -0.30, a 21.1% beat against the -0.38 consensus.
| Metric | Q1 24 | Q2 24 | Q3 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -0.35 | -0.42 | -0.46 | -0.47 | -0.54 | -0.45 | -0.37 | -0.30 | - | - | - | - | - | - | - | - | |||||||||||
| High Estimate | -0.36 | -0.38 | -0.47 | -0.46 | -0.43 | -0.49 | -0.30 | -0.36 | -0.38 | -0.34 | -0.33 | -0.03 | -0.24 | -0.31 | -0.33 | -0.23 | |||||||||||
| Low Estimate | -0.40 | -0.42 | -0.51 | -0.50 | -0.49 | -0.53 | -0.34 | -0.40 | -0.42 | -0.40 | -0.35 | -0.03 | -0.26 | -0.35 | -0.37 | -0.27 | |||||||||||
| Consensus Estimate | -0.38 | -0.40 | -0.49 | -0.48 | -0.46 | -0.51 | -0.32 | -0.38 | -0.40 | -0.37 | -0.34 | -0.03 | -0.25 | -0.33 | -0.35 | -0.25 |